These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 24704832

  • 1. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway.
    Havel JJ, Li Z, Cheng D, Peng J, Fu H.
    Oncogene; 2015 Mar 19; 34(12):1487-98. PubMed ID: 24704832
    [Abstract] [Full Text] [Related]

  • 2. [Research progress in PRAS40].
    Chen G, Zhu G, Zhang X.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jun 28; 43(6):685-690. PubMed ID: 30110013
    [Abstract] [Full Text] [Related]

  • 3. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W, Ye Q, Liu S, She QB.
    Oncotarget; 2015 Jun 10; 6(16):13962-77. PubMed ID: 25961827
    [Abstract] [Full Text] [Related]

  • 4. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.
    Goudarzi KM, Nistér M, Lindström MS.
    Cancer Biol Ther; 2014 Jun 10; 15(11):1499-514. PubMed ID: 25482947
    [Abstract] [Full Text] [Related]

  • 5. Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1.
    Völkers M, Toko H, Doroudgar S, Din S, Quijada P, Joyo AY, Ornelas L, Joyo E, Thuerauf DJ, Konstandin MH, Gude N, Glembotski CC, Sussman MA.
    Proc Natl Acad Sci U S A; 2013 Jul 30; 110(31):12661-6. PubMed ID: 23842089
    [Abstract] [Full Text] [Related]

  • 6. The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling.
    Rapley J, Oshiro N, Ortiz-Vega S, Avruch J.
    J Biol Chem; 2011 Nov 04; 286(44):38043-38053. PubMed ID: 21914810
    [Abstract] [Full Text] [Related]

  • 7. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
    Gordon BS, Kazi AA, Coleman CS, Dennis MD, Chau V, Jefferson LS, Kimball SR.
    Cell Signal; 2014 Mar 04; 26(3):461-7. PubMed ID: 24316235
    [Abstract] [Full Text] [Related]

  • 8. p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage.
    Cam M, Bid HK, Xiao L, Zambetti GP, Houghton PJ, Cam H.
    J Biol Chem; 2014 Feb 14; 289(7):4083-94. PubMed ID: 24366874
    [Abstract] [Full Text] [Related]

  • 9. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα).
    Dan HC, Ebbs A, Pasparakis M, Van Dyke T, Basseres DS, Baldwin AS.
    J Biol Chem; 2014 Sep 05; 289(36):25227-40. PubMed ID: 24990947
    [Abstract] [Full Text] [Related]

  • 10. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.
    Astle MV, Hannan KM, Ng PY, Lee RS, George AJ, Hsu AK, Haupt Y, Hannan RD, Pearson RB.
    Oncogene; 2012 Apr 12; 31(15):1949-62. PubMed ID: 21909130
    [Abstract] [Full Text] [Related]

  • 11. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation.
    Wang L, Harris TE, Lawrence JC.
    J Biol Chem; 2008 Jun 06; 283(23):15619-27. PubMed ID: 18372248
    [Abstract] [Full Text] [Related]

  • 12. PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex.
    Fonseca BD, Smith EM, Lee VH, MacKintosh C, Proud CG.
    J Biol Chem; 2007 Aug 24; 282(34):24514-24. PubMed ID: 17604271
    [Abstract] [Full Text] [Related]

  • 13. TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression.
    Maity S, Das F, Kasinath BS, Ghosh-Choudhury N, Ghosh Choudhury G.
    J Biol Chem; 2020 Oct 16; 295(42):14262-14278. PubMed ID: 32732288
    [Abstract] [Full Text] [Related]

  • 14. Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.
    Wang H, Zhang Q, Wen Q, Zheng Y, Lazarovici P, Jiang H, Lin J, Zheng W.
    Cell Signal; 2012 Jan 16; 24(1):17-24. PubMed ID: 21906675
    [Abstract] [Full Text] [Related]

  • 15. Over-expression of PRAS40 enhances insulin sensitivity in skeletal muscle.
    Wiza C, Chadt A, Blumensatt M, Kanzleiter T, Herzfeld De Wiza D, Horrighs A, Mueller H, Nascimento EB, Schürmann A, Al-Hasani H, Ouwens DM.
    Arch Physiol Biochem; 2014 May 16; 120(2):64-72. PubMed ID: 24576065
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of PRAS40(T246A) in the Proliferative Compartment Suppresses mTORC1 Signaling, Keratinocyte Migration, and Skin Tumor Development.
    Rho O, Srivastava J, Cho J, DiGiovanni J.
    J Invest Dermatol; 2016 Oct 16; 136(10):2070-2079. PubMed ID: 27349859
    [Abstract] [Full Text] [Related]

  • 17. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
    Oshiro N, Takahashi R, Yoshino K, Tanimura K, Nakashima A, Eguchi S, Miyamoto T, Hara K, Takehana K, Avruch J, Kikkawa U, Yonezawa K.
    J Biol Chem; 2007 Jul 13; 282(28):20329-39. PubMed ID: 17517883
    [Abstract] [Full Text] [Related]

  • 18. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
    Chen H, Han L, Tsai H, Wang Z, Wu Y, Duo Y, Cao W, Chen L, Tan Z, Xu N, Huang X, Zhuang J, Huang L.
    Oncotarget; 2016 Dec 13; 7(50):83241-83257. PubMed ID: 27829214
    [Abstract] [Full Text] [Related]

  • 19. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
    Zeng Q, Qin S, Zhang H, Liu B, Qin J, Wang X, Zhang R, Liu C, Dong X, Zhang S, Huang S, Chen L.
    J Cell Physiol; 2018 Jan 13; 233(1):516-529. PubMed ID: 28300280
    [Abstract] [Full Text] [Related]

  • 20. Role of PRAS40 in Akt and mTOR signaling in health and disease.
    Wiza C, Nascimento EB, Ouwens DM.
    Am J Physiol Endocrinol Metab; 2012 Jun 15; 302(12):E1453-60. PubMed ID: 22354785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.